Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1110-1116

  Wu, Hongyang ^a   Ma, Yihui ^a   Zhu, Youkai ^a   Shen, Yan ^a   Gu, Congming ^a   Ye, Ziyin ^a   Lin, Hanliang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

BIRC7; Immunohistochemistry; Inhibitor of apoptosis protein; Non Hodgkin's lymphoma; RT PCR

Indexed keywords

GLYCOPROTEIN P; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BIRC7; PROTEIN P53; SURVIVIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER STAGING; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; T CELL LYMPHOMA; TISSUE MICROARRAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; JURKAT CELLS; K562 CELLS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 33746301984     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500472271     Document Type: Article

References (36)

1. LaCasse, E and Baird, S and Korneluk, R and MacKenzie, A. (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene, 17, pp. 3247-3259.
2. Clem, R and Sheu, T and Richter, B and He, W and Thornberry, N and Duckett, C and Hardwick, J. (2001) c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment J Biol Chem, 276, pp. 7602-7608.
3. Ueda, T and Akiyama, N and Sai, H and Oya, N and Noda, M and Hiraoka, M and Kizaka-Kondoh. (2001) c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites FEBS Lett, 491, pp. 40-44.
4. Young, S and Liston, P and Xuan, J and McRoberts, C and Lefebvre, C and Korneluk, R. (1999) Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2 Mamm Genome, 10, pp. 44-48.
5. Ikeda, J. (1997) Neuronal apoptosis inhibitory protein NAIP and its related nerve degenerate disorder Nippon Ika Daigaku Zasshi, 64, pp. 471-474.
6. Ambrosini, G and Adida, C and Altieri, D. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med, 3, pp. 917-921.
7. Shinozawa, I and Inokuchi, K and Wakabayashi, I and Dan, K. (2000) Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies Leuk Res, 24, pp. 965-970.
8. Suzuki, Y and Nakabayashi, Y and Takahashi, R. (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death Proc Natl Acad Sci USA, 98, pp. 8662-8667.
9. Qiu, X and Goldberg, A. (2005) The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9 J Biol Chem, 280, pp. 174-182.
10. Richter, B and Mir, S and Eiben, L and Lewis, J and Reffey, S and Frattini, A and et al. (2001) Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family Mol Cell Biol, 21, pp. 4292-4301.
11. Ashhab, Y and Alian, A and Polliack, A and Panet, A and Ben Yehuda, D. (2001) Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern FEBS Lett, 495, pp. 56-60.
12. Kasof, G and Gomes, B. (2001) Livin, a novel inhibitor of apoptosis protein family member J Biol Chem, 276, pp. 3238-3246.
13. Lin, J and Deng, G and Huang, Q and Morser, J. (2000) KIAP, a novel member of the inhibitor of apoptosis protein family Biochem Biophys Res Commun, 279, pp. 820-831.
14. Vucic, D and Stennicke, H and Pisabarro, M and Salvesen, G and Dixit, V. (2000) ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas Curr Biol, 10, pp. 1359-1366.
15. Gazzaniga, P and Gradilone, A and Giuliani, L and Gandini, O and Silvestri, I and Nofroni, I and (2003) Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer Ann Oncol, 14, pp. 85-90.
16. Muller, A and Ihorst, G and Mertelsmann, R and Engelhardt, M. (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology Ann Hematol, 84, pp. 1-12.
17. Canellos, G. (2004) Lymphoma: Present and future challenges Semin Hematol, 41(Suppl 7), pp. 26-31.
18. Gu, Xia and Lin, Hanliang and Shen, Yan and Ru, Jingshun and Zhou, Wei and Sun, Yi. (2005) Expression and significance of survivin and bcl-2 in lymphomas J Clin Exp Pathol, 21, pp. 159-163.
19. Ansell, S and Arendt, B and Grote, D and Jelinek, D and Novak, A and Wellik, L and et al. (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma Leukemia, 18, pp. 616-623.
20. Schlette, E and Medeiros, L and Goy, A and Lai, R and Rassidakis, G. (2004) Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma J Clin Oncol, 22, pp. 1682-1688.
21. Nachmias, B and Ashhab, Y and Ben-Yehuda, D. (2004) The inhibitor of apoptosis protein family (IAPs): An emerging therapeutic target in cancer Semin Cancer Biol, 14, pp. 231-243.
22. Jaffe, E and Stein, H and Vardiman, J.(2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. Lyon: IARC Press.
23. Kononen, J and Bubendorf, L and Kallioniemi, A and Barlund, M and Schraml, P and Leighton, S and et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med, 4, pp. 844-847.
24. Pileri, S and Ascani, S and Sabattini, E and Fraternali-Orcioni, G and Poggi, S and Piccioli, M and et al. (2000) The pathologist's view point. Part II - aggressive lymphomas Haematologica, 85, pp. 1308-1321.
25. Kutok, J and Aster, J. (2002) Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma J Clin Oncol, 20, pp. 3691-3702.
26. Sun, J and Liao, R and Chen, Z and Wang, Z and Zhang, Q and Wu, W. (2004) Expression of Livin, a novel inhibitor of apoptosis protein family member, in tissues of non-small cell lung cancer Chongqing Med J, 33, pp. 982-984.
27. Yagihashi, A and Asanuma, K and Tsuji, N and Torigoe, T and Sato, N and Hirata, K and Watanabe, N. (2003) Detection of anti-livin antibody in gastrointestinal cancer patients Clin Chem, 49, pp. 1206-1208.
28. Yagihashi, A and Ohmura, T and Asanuma, K and Kobayashi, D and Tsuji, N and Torigoe, T and et al. (2005) Detection of autoantibodies to survivin and livin in sera from patients with breast cancer Clin Chim Acta, 362, pp. 125-130.
29. Tanabe, H and Yagihashi, A and Tsuji, N and Shijubo, V and Abe, S and Watanabe, N. (2004) Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer Lung Cancer, 46, pp. 299-304.
30. Conway, E and Pollefeyt, S and Cornelissen, J and DeBaere, I and Steiner-Mosonyi, M and Ong, K and et al. (2000) Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions Blood, 95, pp. 1435-1442.
31. Sanna, M and da Silva Correia, J and Ducrey, O and Lee, J and Nomoto, K and Schrantz, N and et al. (2002) IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition Mol Cell Biol, 22, pp. 1754-1766.
32. Vucic, D and Deshayes, K and Ackerly, H and Pisabarro, M and Kadkhodayan, S and Fairbrother, W and Dixit, V. (2002) SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) J Biol Chem, 277, pp. 12275-12279.
33. Yang, Q and Church-Hajduk, R and Ren, J and Newton, M and Du, C. (2003) Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis Genes Dev, 17, pp. 1487-1496.
34. Krasznai, Z and Friedlander, E and Nagy, A and Szabo, G and Vereb, G and Goda, K and Hernadi, Z. (2005) Quantitative and functional assay of MDR1/ P170-mediated MDR in ascites cells of patients with ovarian cancer Anticancer Res, 25, pp. 1187-1192.
35. Nachmias, B and Ashhab, Y and Bucholtz, V and Drize, O and Kadouri, L and Lotem, M and et al. (2003) Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: Implications for drug-resistant melanoma Cancer Res, 63, pp. 6340-6349.
36. Qiuping, Z and Jei, X and Youxin, J and Wei, J and Chun, L and Jin, W and et al. (2004) CC chemokine ligand 25 enhances resistance to apoptosis in CD4 + T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation Cancer Res, 64, pp. 7579-7587.